NETWORKING & COMMUNITY / LATEST NEWS

Do you have important news to share with us? ESGCT members are invited to send their news items to office@esgct.eu to share via our website and social media.

T2EVOLVE Association Launches to Advance Collaboration and Innovation in Advanced Cell Therapies Across Europe

For more information, clic here

3 days ago

AMM-Only Project Pioneers Grant Programme 2026: Funding Innovative Research in Duchenne Muscular Dystrophy - Applications Now Open

AMM-Only Project, a Monaco-based association dedicated to advancing research in Duchenne muscular dystrophy (DMD) and related neuromuscular diseases, is pleased to announce the opening of applications for the 2026 edition of the Pioneers Grant Programme. Launched in 2025, the Pioneers Grant Programme was created to accelerate scientific discovery and the development of innovative therapeutic approaches for Duchenne muscular dystrophy and other neuromuscular disorders. The pro

Jul 1

Genome Engineering : Research and Applications

July 6–9, 2026 | Porto, Portugal | Sheraton Porto Hotel & Spa KEYNOTE SPEAKER Luigi Naldini, MD, PhD

Apr 16

MOOC on gene and gene-based cell therapies for rare diseases

Foundation For Rare Diseases (Fondation Maladies Rares, France) organises an online MOOC on gene and gene-based cell therapies for rare diseases . The course features contributions from leading U.S. and European researchers — including Alain Fischer, Heather Gray Edwards, Alessio Cantore, Zoltan Ivics, Sylvie Odent, Salima Hacein-Bey-Abina, Manuel Gonçalves, Marina Cavazzana, Allison Bradbury, Anne Galy, Chantal Pichon, Claire Booth, Jeffrey Medin , among others — as well a

Apr 10

In memory of Professor Claudio Bordignon

ESGCT are greatly saddened by the loss of Professor Claudio Bordignon, a pioneer in the gene therapy field, and the first President of the ESGCT.

Apr 1